Trial Profile
For an 8-week, Single Center, Randomized, Double Blind, Placebo Controlled Exploratory Clinical Study to Assess the Efficacy, Dose Response and Safety of PG201 Tablet in Patients With Osteoarthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs PG 201 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Helixmith; ViroMed
- 22 May 2014 New trial record